Literature DB >> 34941487

En bloc transurethral resection of bladder tumors: A review of current techniques.

Stefanie M Croghan1, Niall Compton1, Rustom P Manecksha2, Ivor M Cullen1, Pádraig J Daly1.   

Abstract

INTRODUCTION: Growing interest surrounds the concept of en bloc transurethral resection of bladder tumors (ERBT). Theoretical advantages include improved adherence to oncological principles and potential yield of superior pathological specimens. Multiple ERBT methods exist. This review summarizes the current evidence regarding application of differing techniques and technologies to ERBT.
METHODS: A systematic review of MEDLINE/EMBASE/Scopus databases was performed, using terms "en bloc," "ERBT," "bladder," and "urinary bladder neoplasm." Template-based data extraction included technique of ERBT, feasibility, tumor size, activation of obturator nerve reflex, operative complications, detrusor muscle sampling rate, and recurrence data.
RESULTS: Multiple approaches to ERBT have evolved, using a variety of energy sources. The feasibility of electrocautery, laser, combined waterjet/electrocautery, and polypectomy snare techniques have been confirmed in achieving ERBT. ERBT appears safe, with a low complication rate. The use of laser energy sources reduces the risk of activating the obturator nerve reflex during lateral wall resections. Otherwise, no energy source is unequivocally superior in achieving ERBT. The rate of detrusor muscle sampling is high with use of ERBT and appears superior to that achieved with conventional TURBT (cTURBT) in multiple comparative studies. A limited number of largely non-randomized trials assess bladder tumor recurrence; current evidence suggests this is similar between ERBT and cTURBT groups.
CONCLUSIONS: ERBT using a variety of technologies is feasible and safe, with a high detrusor muscle sampling rate. Further research is required to determine whether rates of residual disease or recurrence can be reduced with ERBT vs. cTURBT.

Entities:  

Year:  2022        PMID: 34941487      PMCID: PMC9119597          DOI: 10.5489/cuaj.7539

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   2.052


  58 in total

1.  En bloc resection improves the identification of muscularis mucosae in non-muscle invasive bladder cancer.

Authors:  Hua Liang; Tao Yang; Kaijie Wu; Dalin He; Jinhai Fan
Journal:  World J Urol       Date:  2019-03-04       Impact factor: 4.226

2.  Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa.

Authors:  Masato Yasui; Jun-Ichi Ohta; Shuntaro Aoki; Hironao Tajirika; Hideyuki Terao; Makoto Funahashi; Masatoshi Moriyama; Hiroyuki Hayashi
Journal:  Int Urol Nephrol       Date:  2021-01-02       Impact factor: 2.370

3.  Thulium Laser Endoscopic En Bloc Enucleation of Nonmuscle-Invasive Bladder Cancer.

Authors:  Roberto Migliari; Andrea Buffardi; Hassan Ghabin
Journal:  J Endourol       Date:  2015-08-03       Impact factor: 2.942

4.  Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder Cancer.

Authors:  Shoubin Li; Yi Jia; Chunhong Yu; Helong Xiao; Liuxiong Guo; Fuzhen Sun; Dong Wei; Panying Zhang; Jingpo Li; Junjiang Liu
Journal:  Urol J       Date:  2020-10-01       Impact factor: 1.510

5.  Overnight Continuous Saline Bladder Irrigation After En Bloc Resection of Bladder Tumor Does Not Improve Oncological Outcomes in Patients Who Have Received Intravesical Chemotherapy.

Authors:  Yongjun Yang; Chao Liu; Xiaoting Yan; Jiawei Li; Xiaofeng Yang
Journal:  Front Oncol       Date:  2021-03-10       Impact factor: 6.244

6.  Green-light laser en bloc resection for primary non-muscle-invasive bladder tumor versus transurethral electroresection: A prospective, nonrandomized two-center trial with 36-month follow-up.

Authors:  Ji Chen; Yong Zhao; Sijun Wang; Xunbo Jin; Peng Sun; Longyang Zhang; Muwen Wang
Journal:  Lasers Surg Med       Date:  2016-07-25       Impact factor: 4.025

7.  Safety and Efficacy of En Bloc Transurethral Resection With 1.9 µm Vela Laser for Treatment of Non-Muscle-invasive Bladder Cancer.

Authors:  Hao Xu; Jun Ma; Zhong Chen; Jun Yang; Huixin Yuan; Tao Wang; Jihong Liu; Weimin Yang; Zhangqun Ye
Journal:  Urology       Date:  2017-12-02       Impact factor: 2.649

8.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

9.  The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer.

Authors:  Bo Cheng; Xiaofu Qiu; Huanhui Li; Guosheng Yang
Journal:  Ther Clin Risk Manag       Date:  2017-08-11       Impact factor: 2.423

10.  Safety, feasibility, and quality of holmium laser en-bloc resection of nonmuscle invasive bladder tumors - A single-center experience.

Authors:  Pankaj N Maheshwari; Amandeep Manjeet Arora; Mahesh S Sane; Vivek Ganesh Jadhao
Journal:  Indian J Urol       Date:  2020-04-07
View more
  2 in total

1.  En-bloc Laser Resection of Bladder Tumors: Where Are We Now?

Authors:  Massimiliano Creta; Giuseppe Celentano; Gianluigi Califano; Roberto La Rocca; Nicola Longo
Journal:  J Clin Med       Date:  2022-06-16       Impact factor: 4.964

Review 2.  A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer.

Authors:  Henglong Hu; Mengqi Zhou; Binrui Yang; Shiwei Zhou; Zheng Liu; Jiaqiao Zhang
Journal:  J Clin Med       Date:  2022-08-28       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.